99-19795. Agency Information Collection Activities; Announcement of OMB Approval; Guidance for Industry: Fast Track Drug Development Programs Designation, Development, and Application Review  

  • [Federal Register Volume 64, Number 148 (Tuesday, August 3, 1999)]
    [Notices]
    [Pages 42134-42135]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 99-19795]
    
    
    -----------------------------------------------------------------------
    
    DEPARTMENT OF HEALTH AND HUMAN SERVICES
    
    Food and Drug Administration
    [Docket No. 98N-0811]
    
    
    Agency Information Collection Activities; Announcement of OMB 
    Approval; Guidance for Industry: Fast Track Drug Development Programs--
    Designation, Development, and Application Review
    
    AGENCY: Food and Drug Administration, HHS.
    ACTION: Notice.
    
    -----------------------------------------------------------------------
    
    [[Page 42135]]
    
    SUMMARY: The Food and Drug Administration (FDA) is announcing that a 
    collection of information entitled ``Guidance for Industry: Fast Track 
    Drug Development Programs--Designation, Development, and Application 
    Review'' has been approved by the Office of Management and Budget (OMB) 
    under the Paperwork Reduction Act of 1995.
    
    FOR FURTHER INFORMATION CONTACT: JonnaLynn P. Capezzuto, Office of 
    Information Resources Management (HFA-250), Food and Drug 
    Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-4659.
    
    SUPPLEMENTARY INFORMATION: In the Federal Register of May 6, 1999 (65 
    FR 24406), the agency announced that the proposed information 
    collection had been submitted to OMB for review and clearance under 44 
    U.S.C. 3507. An agency may not conduct or sponsor, and a person is not 
    required to respond to, a collection of information unless it displays 
    a currently valid OMB control number. OMB has now approved the 
    information collection and has assigned OMB control number 0910-0389. 
    The approval expires on June 30, 2002. A copy of the supporting 
    statement for this information collection is available on the Internet 
    at ``http://www.fda.gov/ohrms/dockets''.
    
        Dated: July 27, 1999.
    William K. Hubbard,
    Senior Associate Commissioner for Policy, Planning and Legislation.
    [FR Doc. 99-19795 Filed 8-2-99; 8:45 am]
    BILLING CODE 4160-01-F
    
    
    

Document Information

Published:
08/03/1999
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice.
Document Number:
99-19795
Pages:
42134-42135 (2 pages)
Docket Numbers:
Docket No. 98N-0811
PDF File:
99-19795.pdf